Immunosuppressants - DMARD, Antimetabolites Flashcards
Disease-modifying antirheumatic drugs (DMARDs) are typically the 1st line treatment for patients with a confirmed diagnosis of RA as they can reduce or prevent joint damage and to use preserve joint integrity and function.
How long do these drugs take before these drugs are effective?
1 - immediately
2 - 1-2 week
3 – 4-6 weeks
4 - 4-12 weeks
3 – 4-6 weeks
Some patients may stop taking them as they dont work straight away
Disease-modifying antirheumatic drugs (DMARDs) are typically the 1st line treatment for patients with a confirmed diagnosis of RA. Are they always used in isolation?
- No
Can be used as a as a single agent or as a combination
Disease-modifying antirheumatic drugs (DMARDs) are typically the 1st line treatment for patients with a confirmed diagnosis of RA. Which of the following is the least important to check at baseline before starting the DMARDs?
1 - FBC
2 - Cardiac enzymes
3 - Serum Creatinine
4 - Aminotransferases (liver enzymes)
5 - ESR and CRP
2 - Cardiac enzymes
- FBC = DMARDs can suppress bone marrow activity and can cause neutropenia and increased risk of infection
- Serum Creatinine = DMARDs can cause renal toxicity
- Aminotransferases (liver enzymes) = DMARDs can cause hepatoxicity
- ESR and CRP
When starting DMARDs for a patient with RA, the following are measured at baseline:
- FBC
- Serum Creatinine
- Aminotransferases (liver enzymes)
- ESR and CRP
How often are these monitored in the 1st 6 weeks?
1 - daily
2 - every 72h
3 - weekly
4 - every 2 weeks
4 - every 2 weeks
Then monthly for 3 months
Then every 3 monthly afterwards
What is generally the 1st line treatment for RA?
1 - Disease-modifying anti-rheumatic drugs (DMARDs) - Methotrexate
2 - non-steroidal drugs
3 - aspirin
4 - corticosteroids
1 - Disease-modifying anti-rheumatic drugs (DMARDs) - Methotrexate
The first line treatment for RA is the disease-modifying anti-rheumatic drug (DMARDs) Methotrexate, typically prescribed SC, hut can be given orally as well. How often is this prescribed?
1 - daily 7.5 – 15mg SC
2 - daily 25mg orally
3 - weekly 7.5 – 15mg SC
4 - weekly 25mg orally
3 - weekly 7.5 – 15mg SC
When starting methotrexate, what supplement are patients advised to take?
1 - Calcipotriol (vitamin D)
2 - Folic acid
3 - Omeprazole
4 - Vitamin C
2 - Folic acid
- given at 5mg/wk
Folic acid taken as methotrexate impairs folic acid synthesis
Which of the following is NOT a common adverse event of methotrexate?
1 - GI problems – Nausea, Stomach upset
2 - Stomatitis (oral mucosa inflammation)
3 - Weight loss
4 - Hair loss
5 - Abnormal liver enzymes
3 - Weight loss
Which of the following is NOT a common serious adverse event of methotrexate?
1 - cardiac toxicity
2 - hepatotoxicity
3 - nephrotoxicity
4 - pulmonary toxicity
5 - myelosuppression
1 - cardiac toxicity
Myelosuppression
1 - Anaemia
2 - Leukopenia
3 - Thrombocytopenia
4 - Pancytopenia
Is methotrexate safe to take during pregnancy?
- no
Contraindicated in pregnancy as used as an abortifacient that can also induce congenital anomalies if taken during pregnancy
Methotrexate is contraindicated in pregnancy as it is used as an abortifacient that can also induce congenital anomalies if taken during pregnancy. Prior to becoming pregnant, how long must patients have stopped taking it by?
1 - 24h
2 - 1 week
3 - 4 weeks
4 - 3 months
4 - 3 months
At least 3 months prior to coneption
Which of the following is NOT an indication for the use of Methotrexate according to the BNF?
1 - RA
2 - Urticaria
3 - Psoriasis
4 - Crohn’s disease
5 - Neoplastic diseases
2 - Urticaria
Leflunomide is a DMARDs used in rheumatology at a dose of 10-20mg/d. Which of the following is NOT a common side effect of this drug?
1 - GI - Diarrhoea, Nausea
2 - Hepatic – transaminitis
3 - Hypotension
4 - Pulmonary (ILD)
5 - Skin – rash, alopecia,
6 - Haematological – leucopoenia
7 - Drug interaction – warfarin
3 - Hypotension
- Causing hypertension
- BP monitoring during the first 3 months of treatment recommended
Monitoring is the same as methotrexate
Leflunomide is a DMARDs used in rheumatology at a dose of 10-20mg/d. Is this a safe drug to take during pregnancy and lactation?
- no
Even when stopping, it can remain at low levels for up to 2 years
Cholestyramine, which binds to bile salts and prevents enterohepatic recirculation of Leflunomide
Which 2 of the following are indications for the use of Leflunomide according to the BNF?
1 - RA
2 - Urticaria
3 - Psoriasis
4 - Crohn’s disease
5 - Neoplastic diseases
1 - RA
]3 - Psoriasis (must be active)